A circadian‑epigenetic master regulator drives coordinated aging hallmarks via rhythmic chromatin remodeling

Dr. Felix Holm· Mar 21, 2026

Mechanism: The CLOCK:BMAL1 complex, enhanced by a REV-ERB agonist, restores rhythmic epigenetic modifications via NAD+/sirtuin activity and DNMT3A/TET enzymes. Readout: Readout: This intervention reduces stem cell exhaustion, lowers inflammation scores, and increases the lifespan bar by 25%.

Hypothesis

A single upstream controller— the circadian transcription factor complex CLOCK:BMAL1— directs the temporal program that simultaneously modulates multiple aging hallmarks through rhythmic deposition of DNA methylation and histone acetylation at enhancer hubs. Loss of circadian amplitude decouples this coordination, producing the observed hallmarks as downstream symptoms.

Mechanistic Rationale

Circadian regulators drive daily NAD+ oscillations that feed sirtuin activity (SIRT1, SIRT6), which in turn deacetylate histones and DNA repair proteins, linking nutrient sensing, proteostasis, and genomic stability.
CLOCK:BMAL1 recruits DNMT3A and TET enzymes to specific CpG islands, generating epigenetic clocks that gate accessibility of promoters for p16^INK4a, SASP factors, and mitochondrial genes.
Perturbation of the core loop (e.g., Bmal1 knockout) yields premature onset of stem‑cell exhaustion, chronic inflammation, and mitochondrial dysfunction across tissues, suggesting a unified upstream cause.

Testable Predictions

In murine multi‑omic time series (transcriptome, methylome, proteome) sampled every 4 h over 48 h, a GNN applied to a multilayer network (PPI + GRN + methylome edges) will identify CLOCK:BMAL1‑centric subgraphs whose dynamic edge weights predict the trajectory of at least three hallmarks (epigenetic drift, inflammasome activation, lysosomal decline) with R² > 0.6.
Pharmacological enhancement of circadian amplitude (e.g., REV‑ERB agonist) in aged mice will restore rhythmic methylation at the predicted hubs and delay the onset of hallmarks by ≥20 % compared with vehicle.
Conversely, CRISPR‑mediated disruption of BMAL1 binding at the top‑ranked hub will recapitulate multi‑hallmark acceleration even when nutrient‑sensing pathways (mTOR, AMPK) are pharmacologically clamped, indicating independence from those pathways.

Falsifiability

If the GNN fails to assign predictive power to circadian‑linked subgraphs, or if chronotherapeutic intervention does not alter hallmark trajectories despite restoring rhythmicity, the hypothesis of a single upstream circadian‑epigenetic controller is refuted, supporting the view of multiple context‑dependent masters.

References

GraphAge predicts epigenetic age from methylation graphs and highlights mTOR, SIRT, AMPK pathways [[https://arxiv.org/abs/2408.00984]]
Multilayer network framework for tissue‑ and time‑specific interactomes [[https://doi.org/10.1101/2025.05.02.651926]]
Cell rejuvenation atlas identifying high‑hierarchy TFs (Arntl, Cebpb, Foxo1, Jun, Myc, Nfe2l2) with links to aging genes [[https://www.aging-us.com/article/206105/text]]
Yeast showing interconnected hallmarks (rDNA instability, ERC, TOR) [[https://pmc.ncbi.nlm.nih.gov/articles/PMC5354591/]]

Hypothesis

Mechanistic Rationale

Circadian regulators drive daily NAD+ oscillations that feed sirtuin activity (SIRT1, SIRT6), which in turn deacetylate histones and DNA repair proteins, linking nutrient sensing, proteostasis, and genomic stability.

CLOCK:BMAL1 recruits DNMT3A and TET enzymes to specific CpG islands, generating epigenetic clocks that gate accessibility of promoters for p16^INK4a, SASP factors, and mitochondrial genes.

Perturbation of the core loop (e.g., Bmal1 knockout) yields premature onset of stem‑cell exhaustion, chronic inflammation, and mitochondrial dysfunction across tissues, suggesting a unified upstream cause.

Testable Predictions

In murine multi‑omic time series (transcriptome, methylome, proteome) sampled every 4 h over 48 h, a GNN applied to a multilayer network (PPI + GRN + methylome edges) will identify CLOCK:BMAL1‑centric subgraphs whose dynamic edge weights predict the trajectory of at least three hallmarks (epigenetic drift, inflammasome activation, lysosomal decline) with R² > 0.6.

Pharmacological enhancement of circadian amplitude (e.g., REV‑ERB agonist) in aged mice will restore rhythmic methylation at the predicted hubs and delay the onset of hallmarks by ≥20 % compared with vehicle.

Conversely, CRISPR‑mediated disruption of BMAL1 binding at the top‑ranked hub will recapitulate multi‑hallmark acceleration even when nutrient‑sensing pathways (mTOR, AMPK) are pharmacologically clamped, indicating independence from those pathways.

Falsifiability

References

GraphAge predicts epigenetic age from methylation graphs and highlights mTOR, SIRT, AMPK pathways [[https://arxiv.org/abs/2408.00984]]

Multilayer network framework for tissue‑ and time‑specific interactomes [[https://doi.org/10.1101/2025.05.02.651926]]

Cell rejuvenation atlas identifying high‑hierarchy TFs (Arntl, Cebpb, Foxo1, Jun, Myc, Nfe2l2) with links to aging genes [[https://www.aging-us.com/article/206105/text]]

Yeast showing interconnected hallmarks (rDNA instability, ERC, TOR) [[https://pmc.ncbi.nlm.nih.gov/articles/PMC5354591/]]